Cargando…
The Highly Productive Thermothelomyces heterothallica C1 Expression System as a Host for Rapid Development of Influenza Vaccines
(1) Influenza viruses constantly change and evade prior immune responses, forcing seasonal re-vaccinations with updated vaccines. Current FDA-approved vaccine manufacturing technologies are too slow and/or expensive to quickly adapt to mid-season changes in the virus or to the emergence of pandemic...
Autores principales: | Keresztes, Gabor, Baer, Mark, Alfenito, Mark R., Verwoerd, Theo C., Kovalchuk, Andriy, Wiebe, Marilyn G., Andersen, Tor Kristian, Saloheimo, Markku, Tchelet, Ronen, Kensinger, Richard, Grødeland, Gunnveig, Emalfarb, Mark |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8877961/ https://www.ncbi.nlm.nih.gov/pubmed/35214607 http://dx.doi.org/10.3390/vaccines10020148 |
Ejemplares similares
-
Preclinical immunogenicity and protective efficacy of a SARS-CoV-2 RBD-based vaccine produced with the thermophilic filamentous fungal expression system Thermothelomyces heterothallica C1
por: Gonzalez-Hernandez, Mariana, et al.
Publicado: (2023) -
A recombinant SARS-CoV-2 receptor-binding domain expressed in an engineered fungal strain of Thermothelomyces heterothallica induces a functional immune response in mice
por: Lazo, Laura, et al.
Publicado: (2022) -
Toxicity and Local Tolerance of a Novel Spike Protein RBD Vaccine Against SARS-CoV-2, Produced Using the C1 Thermothelomyces Heterothallica Protein Expression Platform
por: Ramot, Yuval, et al.
Publicado: (2022) -
A DNA Vaccine That Targets Hemagglutinin to Antigen-Presenting Cells Protects Mice against H7 Influenza
por: Andersen, Tor Kristian, et al.
Publicado: (2017) -
Trimeric, APC-Targeted Subunit Vaccines Protect Mice against Seasonal and Pandemic Influenza
por: Tjärnhage, Elias, et al.
Publicado: (2023)